Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are ...

Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as ...

Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...

If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.

The pharmaceutical giant's journey with Celonis has evolved from operational efficiency to enabling enterprise AI ...

This week, Merck filed a notice in accordance with New Jersey's WARN Act, indicating it plans to eliminate 58 positions at ...

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

Merck in 2019 inked a deal to evaluate the combination of its blockbuster cancer drug Keytruda with Pacdev from Astellas and Seagen, which Pfizer acquired in a $43 billion deal that closed in late ...